APA (7th ed.) Citation

Wang, J., Wang, X., Chen, R., Liang, M., Li, M., Ma, G., . . . Wang, S. (2022). Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer. International Journal of Clinical Oncology, 27(5), 889. https://doi.org/10.1007/s10147-022-02125-9

Chicago Style (17th ed.) Citation

Wang, Ji, Xinyang Wang, Rui Chen, Mengdi Liang, Minghui Li, Ge Ma, Tiansong Xia, and Shui Wang. "Circulating Tumor Cells May Serve as a Supplement to RECIST in Neoadjuvant Chemotherapy of Patients with Locally Advanced Breast Cancer." International Journal of Clinical Oncology 27, no. 5 (2022): 889. https://doi.org/10.1007/s10147-022-02125-9.

MLA (9th ed.) Citation

Wang, Ji, et al. "Circulating Tumor Cells May Serve as a Supplement to RECIST in Neoadjuvant Chemotherapy of Patients with Locally Advanced Breast Cancer." International Journal of Clinical Oncology, vol. 27, no. 5, 2022, p. 889, https://doi.org/10.1007/s10147-022-02125-9.